Skip to content

An Investigation of Sleep Disturbance In Patients With Chronic Low Back Pain

A Polysomnographic Investigation of Sleep Disturbance In Patients With Chronic Low Back Pain - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076519
Enrollment
32
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M999- Biomechanical lesion, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Jamia Millia Islamia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Chronic Low back Pain more than twelve weeks and less than seven years NPRS score of 3-7 participant who are healthy and free from physical illness Willingness to participate in the present study Working knowledge of the English language (to fill out the questionnaires and consent form)

Exclusion criteria

Exclusion criteria: They will have a history of low back pain � 7 years, leading to the development of coping with pain skills more than 50 years of age because of the decrease in slow wave sleep (SWS) that occurs in this age group Cognitive impairment that would limit their participation Participant who will be taking heavy caffeine (more than 350 mg/day), alcohol (more than 5 standard drinks per week), or other recreational drugs Participant who will be performing intense regular physical exercise Participant dealing with major life stress situations, such as examination preparation, job seeking, etc. Participant already diagnosed with any sleep disorders Participant having any lifestyle disorders (hypertension, diabetes, hypothyroidism, etc) Subjects having chronic secondary musculoskeletal pain (pain due to inflammatory conditions, infections, auto-immune disease, nervous system disease, local structural musculoskeletal changes) Participant consuming any anti-inflammatory, antidepressant drugs such as benzodiazepine, B-blockers, or any other psychotic drugs that can affect pain, autonomic function, and sleep. Psychological disorders, cognitive impairment for atleast six weeks Any associated cardiovascular disease (valvular heart disease, coronary artery disease, recent myocardial infarction, etc.)

Design outcomes

Primary

MeasureTime frame
Objective sleep Pain intensity Functional disability Timepoint: On day 1

Secondary

MeasureTime frame
Subjective sleep quality Quality of lifeTimepoint: On Day 1

Countries

India

Contacts

Public ContactMd Furquan

Centre For Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia

veqar.zubia@gmail.com9958993486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026